In a retrospective international study, circulating MIR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy

Kidney International

Volumn 89, Issue 3, 2016, Pages 683-692

  Serino, Grazia ^a,b   Pesce, Francesco ^c   Sallustio, Fabio ^a,d   De Palma, Giuseppe ^a   Cox, Sharon N ^a   Curci, Claudia ^a   Zaza, Gianluigi ^e   Lai, Kar N ^f   Leung, Joseph C K ^f   Tang, Sydney C W ^f   Papagianni, Aikaterini ^g   Stangou, Maria ^g   Goumenos, Dimitrios ^h   Gerolymos, Miltiadis ^h   Takahashi, Kazuo ⁱ   Yuzawa, Yukio ⁱ   Maruyama, Shoichi ^j   Imai, Enyu ^j   Schena, Francesco P ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF SALENTO   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^h UNIVERSITY HOSPITAL OF PATRAS   (Greece)

ⁱ FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

biomarker; IgA nephropathy; microRNA; serum

Indexed keywords

GALACTOSE; IMMUNOGLOBULIN A1; MICRORNA; MICRORNA 148B; MICRORNA LET 7B; PREDNISONE; UNCLASSIFIED DRUG; GENETIC MARKER; MIRN148 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; EAST ASIAN; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; GENETIC MARKER; GENETICS; GLOMERULONEPHRITIS, IGA; GREECE; HONG KONG; ITALY; JAPAN; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY;

ADULT; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GLOMERULONEPHRITIS, IGA; GREECE; HONG KONG; HUMANS; ITALY; JAPAN; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84947560275     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.333     Document Type: Article

References (46)

1. R.J. Wyatt, and B.A. Julian IgA nephropathy N Engl J Med 368 2013 2402 2414
2. J. Heaf, H. Lökkegard, and S. Larsen The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997 Nephrol Dial Transplant 14 1999 1889-1889
3. E.M. Briganti, J. Dowling, M. Finlay, and et al. The incidence of biopsy-proven glomerulonephritis in Australia Nephrol Dial Transplant 16 2001 1364-1367
4. Y.H. Park, J.Y. Choi, H.S. Chung, and et al. Hematuria and proteinuria in a mass school urine screening test Pediatr Nephrol 20 2005 1126 1130
5. P. Shen, X. Ding, J. Ten, and et al. Clinicopathological characteristics and outcome of adult patients with hematuria and/or proteinuria found during routine examination Nephron Clin Pract 103 2006 c149 c156
6. M.G. Radford Jr., J.V. Donadio Jr., E.J. Bergstrahl, and et al. Predicting renal outcome in IgA Nephropathy J Am Soc Nephrol 8 2007 199 207
7. A. Amore, P. Cirina, G. Conti, and et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells J Am Soc Nephrol 12 2001 1862 1871
8. J. Barratt, and J. Feehally IgA nephropathy J Am Soc Nephrol 16 2005 2088 2097
9. Z. Moldoveanu, R.J. Wyatt, J.Y. Lee, and et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels Kidney Int 71 2007 1148 1154
10. A.G. Gharavi, Z. Moldoveanu, R.J. Wyatt, and et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy J Am Soc Nephrol 19 2008 1008 1014
11. S. Shimozato, Y. Hiki, H. Odani, and et al. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy Nephrol Dial Transplant 23 2008 1931 1939
12. G. Serino, F. Sallustio, S.N. Cox, and et al. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy J Am Soc Nephrol 23 2012 814 824
13. G. Serino, F. Sallustio, C. Curci, and et al. Role of let-7b in the deregulation process of IgA1 glycosylation in IgA nephropathy Nephrol Dial Transplant 30 2015 1132 1139
14. H. Odani, Y. Hiki, M. Takahashi, and et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 FcO-glycosylated hinge peptides in IgA nephropathy by mass spectrometry Biochem Biophys Res Commun 271 2000 268 274
15. G.K. Wang, J.Q. Zhu, J.T. Zhang, and et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur Heart J 31 2010 659 666
16. O. Waidmann, V. Bihrer, T. Pleli, and et al. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection J Viral Hepat 19 2012 e58 e65
17. C.H. Lawrie, S. Gal, H.M. Dunlop, and et al. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diffuse large B-cell lymphoma Br J Haematol 141 2008 672 675
18. G. Marcucci, M.D. Radmacher, K. Maharry, and et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia N Engl J Med 358 2008 1919 1928
19. K. Zen, and C.Y. Zhang Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers Med Res Rev 32 2012 326 348
20. A. Etheridge, I. Lee, L. Hood, and et al. Extracellular microRNA: a new source of biomarkers Mutat Res 717 2011 85 90
21. H. Liu, L. Zhu, B. Liu, and et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer Cancer Lett 316 2012 196 203
22. M. Tanaka, K. Oikawa, M. Takanashi, and et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients PLoS One 4 2009 e55323
23. K. Wang, S. Zhang, B. Marzolf, and et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc Natl Acad Sci USA 106 2009 4402 4407
24. F.P. Schena, G. Serino, and F. Sallustio MicroRNAs in kidney diseases. New promising biomarkers for diagnosis and monitoring Nephrol Dial Transplant 29 2014 755 763
25. H. Zhou, S.A. Hasni, P. Perez, and et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1 J Am Soc Nephrol 24 2013 1073 1087
26. J. Ji, J. Shi, A. Budhu, and et al. MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
27. A.C. Allen, E.M. Bailey, P.E. Brenchley, and et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients Kidney Int 60 2001 969 973
28. Y. Hiki, H. Odani, M. Takahashi, and et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy Kidney Int 59 2001 1077 1085
29. H. Suzuki, Z. Moldoveanu, S. Hall, and et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 J Clin Invest 118 2008 629 639
30. H. Yanagawa, H. Suzuki, Y. Suzuki, and et al. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases PLoS One 9 2014 e98081
31. I. Hazan-Halevy, D. Rosenblum, S. Weinstein, and et al. Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and nonmalignant B-lymphocytes Cancer Lett 364 2015 59 69
32. M. Mittelbrunn, C. Gutiérrez-Vázquez, C. Villarroya-Beltri, and et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigenpresenting cells Nat Commun 2 2011 282
33. E. Segura, S. Amigorena, and C. Théry Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses Blood Cells Mol Dis 35 2005 89 93
34. G. Raposo, D. Tenza, S. Mecheri, and et al. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation Mol Biol Cell 8 1997 2631 2645
35. J. Büning, D. von Smolinski, K. Tafazzoli, and et al. Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes Immunology 125 2008 510 521
36. M. Chiba, M. Kimura, and S. Asari Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines Oncol Rep 28 2012 1551 1558
37. H. Valadi, K. Ekstrom, A. Bossios, and et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
38. D.C. Cattran, R. Coppo, H.T. Cook, and et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification Kidney Int 76 2009 534 545
39. I.S. Roberts, H.T. Cook, S. Troyanov, and et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility Kidney Int 76 2009 546 556
40. D.E. Ho, K. Imai, G. King, and et al. MatchIt: nonparametric reprocessing for Parametric Causal Inference J Stat Softw 42 2011 1 28
41. A.S. Levey, L.A. Stevens, C.H. Schmid, and et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
42. J.S. Moore, R. Kulhavy, M. Tomana, and et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins Mol Immunol 44 2007 2598 2604
43. R Core Team R: A Language and Environment for Statistical Computing 2014 R Foundation for Statistical Computing Vienna, Austria
44. J.M. Taylor, D.P. Ankerst, and R.R. Andridge Validation of biomarker-based risk prediction models Clin Cancer Res 14 2008 5977 5983
45. A.K. Akobeng Understanding diagnostic tests 3: receiver operating characteristic curves Acta Paediatr 96 2007 644 647
46. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845